Veterinary and dental practice acquisitions operate at the intersection of corporate law, healthcare regulatory compliance, and the specific licensing frameworks that govern who may own, manage, and profit from a licensed professional practice. The consolidation activity reshaping both sectors in 2026 has produced a generation of buyers who understand platform economics and earnout structures but have underestimated the regulatory complexity that determines whether a deal structure is legally permissible in the states where the target operates. This guide addresses the legal mechanics that govern veterinary and dental DSO and MSO transactions, written for buyers, sellers, platform operators, and advisors who need a clear framework before committing to a transaction structure.
2026 Veterinary and Dental Consolidation Landscape: Platform Operators and Market Structure
The veterinary and dental sectors entered 2026 as two of the most actively consolidated professional practice markets in the United States, each driven by private equity capital seeking recurring revenue, fragmented markets with significant independent operator populations, and demographic trends that support long-term demand growth.
In veterinary medicine, the largest consolidators operate at substantial scale. Mars Veterinary Health, through its VCA and Banfield subsidiaries, operates thousands of locations across the country and represents the most integrated platform in the sector. IVC Evidensia, backed by European private equity, has expanded its U.S. presence through targeted acquisitions of independent and group practices. National Veterinary Associates operates a portfolio spanning general practice, emergency, and specialty care. BluePearl Veterinary Partners, a Mars subsidiary, focuses specifically on specialty and emergency referral centers, a segment that commands premium valuations because of the specialist credentialing and 24-hour staffing model that distinguishes it from general practice.
In dental, the DSO model has produced several large-scale operators. Heartland Dental manages practices across dozens of states under full-service dental support organization agreements. Aspen Dental operates under a franchise-adjacent model that blends corporate management with individual practice ownership. Smile Brands manages a portfolio of branded practices across multiple states. Pacific Dental Services and Dental Care Alliance each operate regional platforms with varying levels of clinical integration. Below these large platforms, hundreds of regional and emerging DSOs are acquiring practices in targeted geographies, creating competitive auction dynamics for quality targets in densely populated markets.
The legal complexity of both sectors derives from the same source: professional licensing laws in most states restrict who may own a licensed professional practice, who may employ a licensed professional in a clinical capacity, and what fee arrangements are permissible between a professional entity and a lay management company. Navigating that complexity requires transaction counsel who understand both the M&A mechanics and the healthcare regulatory framework that shapes every permissible deal structure.
Deal Structures: Equity Rollover, Earnout, Working Capital, and Clinical Hold-Back
The economic structure of a veterinary or dental practice acquisition involves several components that interact with the regulatory framework and that must be calibrated to the specific practice profile, the state of operation, and the buyer's integration strategy.
Equity rollover is a standard component of DSO and veterinary platform acquisitions. The selling practitioner retains a minority equity interest in the acquiring entity, the MSO vehicle, or a practice-level holding company, creating alignment between the seller's continued clinical performance and the buyer's return on acquisition capital. Rollover percentages in veterinary transactions typically range from ten to thirty percent of the total transaction value, depending on the buyer's preference for alignment and the seller's willingness to accept equity risk in the acquiring platform. In states with CPOM restrictions, the structure of the rollover must be carefully designed so that the selling practitioner's equity interest does not create a lay ownership problem in the professional entity. The rollover is typically structured in the MSO or holding company layer, not in the professional clinical entity.
Earnouts in dental and veterinary transactions are tied to practice performance metrics over a defined period after closing, typically one to three years. Common earnout metrics include revenue, EBITDA, or patient/client visit counts. Earnouts create alignment incentives but also create disputes when post-closing integration decisions by the buyer affect the metrics on which the earnout is calculated. A seller whose earnout is tied to revenue must be protected from buyer-initiated changes to pricing, service mix, or referral relationships that suppress revenue during the earnout period. Conversely, a buyer must ensure that the earnout does not incentivize the seller to defer capital expenditures, defer necessary associate hires, or maintain an unsustainable patient load to maximize short-term metrics. Precision in earnout definition, including the methodology for calculating the metric, the treatment of extraordinary items, and the buyer's obligation to operate the practice in a manner consistent with past practice during the earnout period, is essential.
Working capital is negotiated as a closing adjustment in virtually every veterinary and dental practice acquisition of meaningful scale. The working capital peg reflects the amount of working capital required to operate the practice in the ordinary course, and the purchase price is adjusted upward if working capital at closing exceeds the peg and downward if it falls short. In veterinary and dental practices, working capital includes accounts receivable net of expected collections, inventory, prepaid expenses, accounts payable, and accrued liabilities. The definition of accounts receivable and the aging assumptions applied to it are frequently contested because practices with significant insurance or third-party payer revenue often carry aged receivables that may not be collectible at face value. A clinical hold-back is a separate purchase price component that may be used when a portion of the practice's value depends on the continuing clinical activity of the selling practitioner. The hold-back is released to the seller over time as the seller meets agreed clinical production targets, providing the buyer with protection against an immediate reduction in clinical output after closing.
Corporate Practice of Medicine, Dentistry, and Veterinary Medicine: Doctrine and Enforceability
The corporate practice of medicine doctrine, and its analogs for dentistry and veterinary medicine, is the legal framework that restricts lay entity ownership and control of licensed professional practices in a majority of states. Understanding the doctrine's scope and the specific form it takes in each relevant state is the threshold legal task in any DSO or veterinary platform transaction.
The CPOM doctrine originated from the view that the professional judgment of a licensed practitioner must not be subordinated to the commercial interests of a lay employer or investor. Courts and regulators in CPOM states have interpreted the doctrine to prohibit a lay entity from employing licensed professionals in a clinical capacity, from controlling clinical decision-making, from holding a financial interest in the professional practice entity, or from entering into arrangements that effectively transfer the economic benefits of clinical operations to a lay party. The doctrine is enforced through state professional licensing statutes, attorney general opinions, state medical, dental, and veterinary board regulations, and, in some states, through litigation brought by competitors, regulators, or whistleblowers under state unfair business practice statutes.
The corporate practice of dentistry doctrine follows a similar analytical framework as CPOM. Most state dental practice acts require that dental practices be owned by licensed dentists or by professional corporations or limited liability companies whose members are licensed dentists. The CPOD doctrine specifically addresses the concern that lay ownership of dental practices would create incentives to perform unnecessary procedures, to reduce clinical staff for cost reasons, or to prioritize revenue over patient care. Several states, including California and New York, have issued dental board opinions that enumerate prohibited lay ownership arrangements and that specifically address the permissibility of DSO management services agreements.
The corporate practice of veterinary medicine doctrine is less uniformly developed than CPOM or CPOD, but a growing number of states have enacted or interpreted their veterinary practice acts to restrict lay ownership of veterinary practices. The doctrine matters most in states where large consolidators have targeted independent practices and where state veterinary boards have begun scrutinizing platform ownership structures. Any transaction involving a veterinary practice in a state with an active CPVM enforcement posture must be structured with the same care as a CPOM-governed dental or medical transaction.
MSO and DSO Structure: Friendly PC Model, Asset Ownership, and Management Fee Calibration
The Management Services Organization structure is the foundational legal architecture for DSO and veterinary platform acquisitions in states with CPOM, CPOD, or CPVM restrictions. The MSO separates ownership and management of administrative assets from ownership of the clinical professional entity, allowing a lay investor to capture the economic value of a professional practice without holding a direct ownership interest in it.
In the friendly PC model, a licensed professional, often the selling practitioner or a practitioner designated by the acquiring entity, holds one hundred percent of the equity in the professional clinical entity. The professional entity holds the state professional licenses, employs or contracts with licensed practitioners, and is the entity that appears on insurance credentialing, DEA registrations, and state controlled substance licenses. The MSO, owned by the investor group, holds all non-clinical assets: real estate or the real estate lease, equipment, technology systems, furniture, signage, brand assets, and employment agreements for non-clinical administrative staff. The MSO provides the professional entity with all administrative services, including billing, scheduling, marketing, compliance, HR, and finance, under a long-term management services agreement.
Asset ownership allocation between the MSO and the professional entity is a structural design decision that has regulatory consequences. In states where the professional entity is restricted to clinical activities, the MSO should hold substantially all physical and intangible assets other than the professional license itself. The professional entity's balance sheet, in a properly structured arrangement, consists primarily of accounts receivable from patients and payers, the management services agreement with the MSO as a payable obligation, and any equipment or supplies that are specifically required to be owned by the licensed entity under state law.
Management fee calibration is both a regulatory requirement and an economic negotiation. The fee must be set at fair market value for the services provided by the MSO, as determined by an independent valuation conducted by a qualified healthcare valuation firm. The fair market value opinion must address the specific services included in the MSO scope, the local market rates for comparable services, and the appropriate margin structure for a management services arrangement of this type. A fee that is clearly below market may suggest that the arrangement is not at arm's length; a fee that captures substantially all net clinical revenue may be challenged as a device for circumventing the CPOM prohibition.
State-by-State CPOM Analysis: Prohibited, Permissive, and Hybrid Jurisdictions
The legal permissibility of a given DSO or veterinary platform transaction structure depends heavily on the state in which the target practice operates. States fall into three broad categories: those that strictly prohibit lay ownership and impose significant restrictions on MSO arrangements, those that are permissive and allow broad flexibility in practice ownership and management, and hybrid states that permit certain structures while restricting others.
California, New York, Illinois, Texas, and New Jersey are the most frequently cited states with strict lay ownership prohibitions. California's Business and Professions Code Section 2052 prohibits the unlicensed practice of medicine, and California courts have interpreted this provision broadly to restrict MSO arrangements that vest too much operational control in the management company. The California Medical Board and Dental Board have each issued guidance addressing the characteristics of permissible and impermissible MSO arrangements. New York's Education Law restricts the corporate practice of medicine and dentistry and requires that professional service corporations be owned exclusively by licensed professionals. The New York Attorney General's office has pursued enforcement actions against lay-owned entities that were functioning as de facto owners of professional practices through aggressive MSO fee structures.
Michigan, Florida, and Arizona are among the states with more permissive approaches to professional practice ownership. Michigan permits professional service corporations and limited liability companies but does not impose the same strict restrictions on lay ownership of management entities that California and New York apply. Florida's professional licensing statutes allow professional associations but are generally interpreted to permit well-structured MSO arrangements where the management company does not directly employ licensed professionals or control clinical decisions. Arizona has been particularly hospitable to DSO structures and has a relatively developed regulatory framework that addresses permissible management arrangements.
Hybrid states present the most complex analytical challenge. States in this category have general prohibitions on lay ownership but have carved out specific permitted structures through statutory amendments, regulatory guidance, or attorney general opinions. Texas, for example, prohibits the corporate practice of medicine under its Medical Practice Act but has specific statutory authority permitting certain management company arrangements for licensed facilities. Illinois restricts the corporate practice of medicine but has developed a body of regulatory guidance that permits MSO structures meeting specific criteria. Transactions involving practices in hybrid states require state-specific legal analysis before the transaction structure is finalized.
DEA Registration Transfer: Form 224, Controlled Substance Licenses, and Timeline Management
Veterinary and dental practices that handle, administer, dispense, or prescribe controlled substances are required to maintain a valid DEA registration under the Controlled Substances Act. For veterinary practices, controlled substances are essential for anesthesia, pain management, and euthanasia. For dental practices, controlled substance prescribing authority covers opioid analgesics and, in oral surgery contexts, intravenous sedation drugs that require careful regulatory compliance.
The DEA registration is specific to the registrant and to the registered address. When a practice is acquired in an asset transaction and the acquiring entity is different from the registered entity, the acquiring entity must apply for a new DEA registration using Form 224 before it begins handling controlled substances. DEA processing times for new registrations have historically ranged from four to six weeks for straightforward applications, but can extend significantly if the application is incomplete or if the registrant or responsible individual has a prior regulatory history requiring additional review. The practical consequence for a transaction is that the buyer may face a period after closing during which it cannot legally handle controlled substances at the acquired practice location if the new DEA registration has not yet been issued.
Interim arrangements for handling this gap require coordination between the seller and the buyer. In some asset transactions, the seller agrees to maintain its DEA registration for a defined transition period while the buyer's application is pending, providing the buyer with access to controlled substances under a documented arrangement. This approach creates regulatory complexity and must be structured carefully to ensure that the seller is not functioning as a shadow registrant while the buyer operates the practice. Counsel should assess the specific facts of the practice's controlled substance use and the likely DEA processing timeline before committing to a closing date.
State controlled substance licenses are distinct from the DEA registration and are issued under state pharmacy or professional licensing statutes. Most states require a separate state controlled substance license in addition to the federal DEA registration. State license transfer rules vary: some states permit assignment of the existing license to the buyer; others require a new application; still others have no specific transfer mechanism and require the buyer to apply for a new license after the existing license lapses. A buyer acquiring a veterinary or dental practice must map the controlled substance licensing requirements in each state where the practice operates and must build the license transition timeline into the closing schedule.
State Veterinary Board and Dental Board Approvals: License Assignment vs. Reissuance
State veterinary and dental boards regulate the licensure of individual practitioners and, in many states, the licensure of the facilities or entities through which those practitioners practice. When a practice changes hands, the applicable state board may require notification, approval of a change of ownership, reissuance of a facility license to the new owner, or some combination of these steps. Failure to comply with board change-of-ownership requirements can result in the buyer operating without a required license, which creates exposure to board enforcement action, fines, and in the most serious cases, an order to cease operations.
The threshold question is whether the state issues a facility license to the practice entity, and if so, whether that license is assignable or must be reissued. Dental facility licenses, which are issued in many states for dental offices as distinct from individual dentist licenses, are generally not assignable. When a dental practice is acquired and the acquiring entity is different from the licensed entity, the acquiring entity must apply for a new facility license before operating. States including California, New York, and Florida have dental facility licensing requirements that operate on this basis, and processing times for new facility licenses can extend the timeline to operational readiness after closing.
State veterinary boards impose analogous requirements for veterinary facility licenses, hospital licenses, or permits. Some states, including California, issue veterinary hospital licenses that must be reissued when ownership changes. The California Veterinary Medical Board requires a new hospital premises permit when ownership transfers, and the application must be submitted in advance of the ownership change. Other states, including Michigan and Texas, have different frameworks that may permit assignment or may have no facility licensing requirement at all, limiting the board's role to oversight of individual practitioner licenses.
The practical approach to board approval risk is to treat the board approval process as a pre-closing obligation and to build the approval timeline into the transaction schedule. Counsel with experience in the relevant state's board processes can assess the realistic timeline, prepare the application, and manage communication with the board during the review period. Deals that close without satisfying board change-of-ownership requirements create post-closing remediation obligations that are more difficult and more expensive to address than the same requirements handled pre-closing.
Clinical Integration and Associate Employment: Non-Compete Enforceability by State
The clinical integration phase of a veterinary or dental platform acquisition centers on transitioning the acquired practice's practitioners from their existing employment or contractor relationships into the acquiring entity's employment or contractor framework. The structure of those relationships must comply with the CPOM doctrine in the relevant states and must account for the enforceability of non-compete and non-solicitation provisions that protect the acquired patient or client relationships.
In states with strict CPOM restrictions, the professional clinical entity, not the MSO, must be the employing entity for licensed practitioners. An MSO that employs veterinarians or dentists directly in a CPOM state is operating in a prohibited manner regardless of the other structural elements of the transaction. The employment agreements for licensed practitioners must be executed with the professional entity as employer, must preserve the practitioner's independent clinical judgment, and must not include provisions that subordinate clinical decisions to MSO direction or approval.
Associate doctor non-compete enforceability varies significantly by state and has become more restricted over the past two years as several states have enacted or expanded non-compete limitations. California's prohibition on employee non-competes under Business and Professions Code Section 16600, reinforced by AB 2288 effective January 1, 2024, applies to associate veterinarians and dentists in California practices. New York's 2024 legislation limits non-compete enforceability for employees below a defined compensation threshold, and ongoing litigation about the scope of that limitation creates uncertainty for New York DSO and veterinary platform operators. Massachusetts post-2018 reform limits non-competes to one year, requires garden leave pay or equivalent consideration, and excludes certain worker categories from non-compete coverage entirely.
In states that permit reasonable non-compete provisions, including Michigan, Florida, and Texas, the enforceability of a non-compete for an associate practitioner depends on the reasonableness of the geographic scope, the duration, and the legitimate business interest being protected. A non-compete tied to patient goodwill transferred in an acquisition transaction occupies a different legal position from a non-compete imposed on a new hire with no prior relationship to the practice, and courts in most states that permit non-competes apply more favorable scrutiny to the former. Buyers should obtain state-specific legal analysis of associate non-compete enforceability before relying on those provisions as a mechanism for protecting the acquired patient base post-closing.
OSHA Compliance: Bloodborne Pathogens, Waste Anesthetic Gas, and X-Ray Radiation Standards
Veterinary and dental practices operate in regulated workplace environments where OSHA standards impose specific compliance obligations on the practice as employer. These obligations are a component of diligence in any practice acquisition because violations are cited at the employer of record and travel with the entity in a stock transaction.
The OSHA Bloodborne Pathogens Standard, 29 CFR 1910.1030, applies to all workplaces where employees may reasonably anticipate occupational exposure to blood or other potentially infectious materials. Both dental and veterinary practices are covered employers. The standard requires written exposure control plans, universal precautions, availability of personal protective equipment, hepatitis B vaccination and post-exposure evaluation, annual training, and recordkeeping. A practice that has not maintained a current exposure control plan, has not documented annual training, or has not made hepatitis B vaccination available to at-risk employees is in violation of the standard and is subject to OSHA citation and penalty upon inspection.
Waste anesthetic gas monitoring is a specific compliance obligation for veterinary practices that use inhalant anesthesia agents such as isoflurane or sevoflurane. NIOSH guidelines establish recommended exposure limits for halogenated anesthetic agents, and OSHA cites waste anesthetic gas exposure violations under the General Duty Clause when employee exposures exceed recommended levels due to inadequate scavenging systems, equipment maintenance failures, or improper anesthesia technique. Diligence on veterinary practice acquisitions should include an assessment of the anesthesia scavenging systems, maintenance records, and any prior air monitoring data to assess the adequacy of the waste anesthetic gas management program.
X-ray radiation safety standards apply to both dental and veterinary practices. OSHA's ionizing radiation standard, 29 CFR 1910.1096, requires practices using X-ray equipment to control employee radiation exposure and maintain appropriate shielding and monitoring. State radiation control programs impose additional requirements, including periodic equipment registration, physicist inspections, and badge monitoring for employees who operate radiation-producing equipment. A practice that has not maintained current state radiation control registrations or that has not implemented required dosimetry monitoring for X-ray operators is subject to state regulatory action in addition to OSHA exposure. Buyers should request copies of the most recent state radiation control inspection reports and any correspondence with state radiation control authorities as part of the environmental and regulatory diligence review.
HIPAA Privacy for Dental Records and State Veterinary Record Retention Requirements
HIPAA's Privacy Rule and Security Rule apply to dental practices as covered entities because dental practices create, maintain, transmit, and use individually identifiable health information in connection with covered healthcare transactions. Veterinary practices are generally not covered entities under HIPAA because veterinary medicine is not a healthcare service as defined by the statute, and animal health records are not individually identifiable health information of a human patient.
For dental practice acquisitions, HIPAA compliance diligence is a mandatory component of the transaction review. The Privacy Rule requires that patients be notified of any change in ownership of their protected health information. When a dental practice is acquired and patient records are transferred to a new covered entity, the new entity must provide patients with a notice of privacy practices reflecting the new entity's identity and contact information. In an asset acquisition where patient records are one of the transferred assets, the transaction itself must be structured so that the transfer of records is permissible under HIPAA's business associate and covered entity framework. The buyer and seller should be operating under a business associate agreement during any transition period when the seller retains access to records that have been transferred to the buyer.
State veterinary record retention requirements impose obligations on veterinary practices that are distinct from HIPAA and that govern how long patient records must be maintained after the date of service or after the patient is last seen. State veterinary practice acts or board regulations in most states specify minimum retention periods ranging from three to seven years, with some states imposing longer requirements for specialty or hospital-based records. When a veterinary practice is acquired and practice management systems are migrated, the acquiring entity must ensure that records subject to the applicable retention period remain accessible in a retrievable format for the full retention period, even if those records are housed in a legacy system that is being decommissioned.
Data security obligations for dental practices extend beyond HIPAA to include state data breach notification laws and state health information privacy statutes that may impose requirements beyond the federal baseline. A dental DSO acquiring practices in multiple states must assess the data security compliance posture of each acquired practice and must implement or verify the existence of appropriate security controls for electronic protected health information before and after closing.
HIPAA and Record Retention Obligations Do Not Disappear at Closing
Buyers who close a dental or veterinary acquisition without assessing the target's HIPAA compliance posture and state record retention obligations inherit those obligations immediately. A security incident involving transferred patient records, or a regulatory inquiry about records that were destroyed prematurely in a system migration, creates post-closing liability that the purchase agreement's indemnification provisions may not adequately address if the issue arose from the buyer's post-closing conduct. Alex Lubyansky leads every engagement personally and can be reached at 248-266-2790.
Request Engagement AssessmentReal Estate Diligence: Landlord Consent, Medical Gas Systems, and Imaging Equipment
Real estate is a frequently underweighted diligence area in veterinary and dental practice acquisitions. The physical space where clinical services are delivered is subject to lease assignment restrictions, specialized infrastructure obligations, and equipment-specific regulatory requirements that do not arise in non-clinical commercial real estate transactions.
Commercial leases for dental and veterinary practice space almost universally contain anti-assignment clauses requiring landlord consent to any assignment, including assignments occurring by operation of an ownership change. In a stock acquisition, the legal entity that is the tenant continues to exist and no formal assignment occurs, but leases with change-of-control provisions may treat a change in majority ownership as a deemed assignment triggering the consent requirement. In an asset acquisition, any assumption of the existing lease requires landlord consent, and the buyer must identify and obtain that consent before closing. Landlords who become aware of a pending transaction may use the consent process as leverage to renegotiate lease terms, extend term lengths on terms favorable to the landlord, or require personal guarantees from the buyer that the seller did not provide.
Medical gas systems in dental practices, including nitrous oxide delivery systems and oxygen supply, require compliance with NFPA 99, the Health Care Facilities Code, and any applicable state building code or dental board requirements governing the installation and maintenance of piped gas systems. A dental practice with a non-compliant medical gas system may face state dental board inspection violations and OSHA citations for inadequate workplace safety controls. Diligence should include a review of the medical gas system installation and maintenance records, confirmation that the system was installed by a certified medical gas installer, and confirmation that required periodic inspections and certifications are current.
Imaging equipment in dental practices, including digital X-ray systems, panoramic radiography units, and cone beam computed tomography machines, and in veterinary practices, including digital radiography and ultrasound equipment, represents significant capital investment that must be evaluated as part of the asset diligence. Equipment ownership must be confirmed through review of purchase agreements, equipment financing documents, and UCC lien searches to determine whether the equipment is owned outright, subject to a capital lease, or financed through a security agreement. Equipment subject to a security agreement requires lender consent to the asset transfer in most circumstances. Leased equipment must be addressed through the lease assignment process. The regulatory compliance status of the imaging equipment, including state radiation control registration, must be verified and any pending inspections or required upgrades must be addressed before the buyer assumes operational responsibility.
Insurance Program Transition: Professional Liability, Tail Coverage, and Claims-Made vs. Occurrence
Insurance program transition is a logistically complex component of any veterinary or dental practice acquisition that requires coordination between the seller's insurance broker, the buyer's insurance program, and the timing of the transaction closing. Gaps in coverage created by an unplanned transition can expose the acquiring entity to uninsured liability for incidents that occurred in the transition period.
Professional liability insurance for dental and veterinary practices is almost universally written on a claims-made basis. A claims-made policy covers claims that are both made during the policy period and arise from incidents that occurred after the policy retroactive date. When a claims-made policy is terminated, any claims reported after the termination date are not covered, regardless of when the underlying incident occurred, unless a tail endorsement has been purchased. The tail endorsement, formally an extended reporting period endorsement, extends the period during which claims can be reported to the insurer for incidents that occurred during the policy period.
The obligation to purchase tail coverage must be negotiated and documented in the purchase agreement. Sellers typically argue that the buyer should fund tail coverage as a transaction cost because the buyer benefits from the clean claims history that the tail protects. Buyers typically argue that tail coverage is a seller obligation because it protects the seller's conduct during the seller's period of ownership. Market practice varies by transaction size, the seller's leverage in the negotiation, and the cost of the tail premium relative to the purchase price. For dental practices performing oral surgery or complex restorative work, and for veterinary practices providing emergency or surgical services, tail premiums can be substantial and should be estimated early in the diligence process.
The buyer's new professional liability coverage must be in place effective at closing. If the buyer is integrating the acquired practice into an existing platform program, the extension of that program to cover the new practice location must be confirmed with the insurer before closing. If the buyer is purchasing new coverage for the acquired practice, the insurance binding must be timed so that coverage is effective on the closing date without a gap between the seller's last day of coverage and the buyer's first day of coverage.
Revenue Cycle and Payer Mix: Insurance Aging, CareCredit, and Pet Insurance
Revenue cycle analysis is a core component of diligence in veterinary and dental practice acquisitions because the quality of the revenue stream, not just its volume, determines whether the acquisition will generate the cash flow necessary to service acquisition costs and support ongoing investment in the practice.
In dental practices, insurance revenue is generated through participation in dental benefit plans administered by carriers including Delta Dental, MetLife, Cigna, Aetna, United Concordia, and regional plans. The payer mix, the contracted fee schedules, and the efficiency of the practice's insurance claims processing and collections operations collectively determine the net revenue generated per procedure. Insurance accounts receivable aging analysis is a standard component of dental diligence and involves reviewing the distribution of outstanding claims by age, carrier, and denial reason to assess the quality of the receivables being acquired and the adequacy of the collections process. Receivables aged more than ninety days from date of service are generally less likely to be collected at face value and should be discounted in any purchase price that includes a working capital component.
Patient financing through CareCredit and comparable healthcare-specific consumer financing platforms is a significant revenue management tool in dental practices. The practice's CareCredit merchant agreement and the associated merchant account are assets that must be addressed in the transaction. In an asset acquisition, the CareCredit merchant agreement must be assigned to the buyer or the buyer must establish a new merchant account, which involves an underwriting process that may take several weeks. Dental practices with high CareCredit penetration in their patient financing mix may face collection disruption during any period when the merchant account is in transition.
Pet insurance has become a material component of veterinary practice revenue mix as Trupanion, Nationwide, and other pet insurance providers have grown their covered lives substantially. Unlike dental insurance, which is billed directly by the practice to the carrier under a provider agreement, most pet insurance in the United States is reimbursement-based: the pet owner pays the practice directly and then submits a claim to the insurer for reimbursement. The practice's revenue is therefore not directly dependent on pet insurance credentialing, but the practice's client mix and collection rates may be affected by the prevalence of insured patients in the practice population. Diligence should assess whether the practice has developed relationships with insurance companies that have led to direct billing arrangements and whether those arrangements will continue post-acquisition.
Representations and Warranties in Medical Practice Acquisitions: Upcoding, Unbundling, Stark Law, and Anti-Kickback
The representations and warranties in a veterinary or dental practice purchase agreement must be calibrated to the specific regulatory risks of the healthcare sector. Standard M&A representations addressing ordinary course operations, material contracts, and employee matters are necessary but not sufficient to protect a buyer from the categories of regulatory exposure that are specific to professional practice acquisitions.
Upcoding and unbundling are billing irregularities that can trigger False Claims Act liability for dental practices billing Medicaid or other government programs, and professional liability exposure in all practice contexts. Upcoding involves billing for a more complex or expensive procedure than was actually performed. Unbundling involves billing separately for components of a procedure that should be billed as a single bundled service under the applicable payer's coding rules. A dental practice with a significant Medicaid or CHIP patient population that has engaged in upcoding or unbundling during the look-back period carries contingent liability that attaches to the entity in a stock acquisition. The representations and warranties should require the seller to represent that all claims submitted to government and commercial payers during the look-back period were submitted accurately and in compliance with applicable coding rules, and that no investigations, audits, or recoupment demands are pending.
The Stark Law, which prohibits physician self-referral under the Medicare program, does not directly apply to dentists or veterinarians, because neither dental services nor veterinary services are covered under Medicare in the traditional sense. However, dental Medicaid programs in most states incorporate Anti-Kickback Statute compliance requirements, and DSO management fee arrangements in states with Medicaid dental programs must be evaluated for Anti-Kickback Statute compliance. A management services arrangement in which the MSO fee is calculated as a percentage of the professional entity's revenue from Medicaid-reimbursed services may implicate the Anti-Kickback Statute unless the arrangement qualifies for protection under the personal services safe harbor. The safe harbor requires that the aggregate compensation under the arrangement be set in advance, consistent with fair market value, and not determined in a manner that takes into account the volume or value of referrals or business generated between the parties.
Reps and warranties insurance has become increasingly available for healthcare practice acquisitions, including dental DSO and veterinary platform transactions. RWI can backstop the seller's representations about billing compliance, regulatory status, and CPOM structure enforceability, providing the buyer with an insurance remedy for breaches that the seller's indemnification capacity cannot cover. For transactions where the seller is a retiring practitioner with limited balance sheet, RWI may be the primary mechanism for protecting the buyer against representations that turn out to be inaccurate post-closing.
Billing Compliance Exposure Does Not Disappear at Closing
A dental practice with a history of upcoding, unbundling, or Medicaid billing irregularities carries that exposure into a stock acquisition regardless of how the purchase price is structured. Buyers who conduct targeted billing diligence before closing, rather than relying on generic healthcare compliance representations, identify these issues when they can still be priced into the transaction. Acquisition Stars structures diligence and representations to give buyers a clear view of billing compliance risk before the deal is signed. Contact Alex Lubyansky at 248-266-2790.
Submit Transaction DetailsPost-Closing Integration: EMR and Practice Management System Migration
Post-closing integration in veterinary and dental platform acquisitions encompasses the operational, technological, and clinical steps required to bring the acquired practice into the platform's standard operating model. The practice management system migration is often the most complex and highest-risk component of that integration process.
Veterinary practice management systems in common use include AVImark, which has a large installed base among general practices; ezyVet, which offers cloud-native architecture and is preferred by many multi-location operators; Cornerstone by IDEXX, which integrates practice management with the IDEXX diagnostic laboratory network; and Covetrus Pulse, which supports inventory management alongside clinical records. Each system has a distinct data model, and migration between systems requires a data mapping exercise that translates the legacy system's record structure into the target system's format. Fields that exist in the legacy system may have no direct analog in the target system, requiring decisions about how to handle orphaned data elements. Legacy appointment histories, treatment records, vaccination records, and financial histories must all be migrated without loss, and the migration must be validated before the legacy system is decommissioned.
Dental practice management systems in common use include Dentrix, the most widely installed system in independent and small-group dental practices; Eaglesoft, which has a significant installed base in the Southeast and Midwest; Open Dental, an open-source system popular among independent practitioners who prefer flexibility over vendor dependency; and Carestream Dental, which integrates imaging workflows with practice management. DSOs acquiring practices that use different legacy systems face a heterogeneous technology landscape that complicates standardization. Practices using Open Dental may have custom modules or configurations that do not migrate cleanly to a proprietary system. Practices using Dentrix may have imaging data stored in Dentrix Imaging that requires a separate migration from the clinical record data.
Revenue cycle disruption during system migration is a material risk that must be planned for in the integration timeline. During a migration window, claims may be submitted late, procedure codes may be mapped incorrectly, and insurance credentialing under the new entity may not yet be complete, resulting in claim rejections that require manual reworking. The integration plan should include a claims monitoring protocol that flags elevated rejection rates during the migration period and an escalation path for addressing rejections before they age beyond the payer's timely filing window. Earnout calculations tied to revenue metrics during the integration period should include an adjustment mechanism or a defined exclusion for revenue disruption attributable to the system migration itself.
eClinicalWorks, while primarily a medical practice management system, appears in some veterinary specialty and multi-specialty practice contexts where the practice has integrated human and animal health services or where the operator has standardized on eClinicalWorks across a mixed healthcare portfolio. Buyers integrating practices using eClinicalWorks into a veterinary-native system must address the same data mapping and validation challenges described above, with the additional complexity of migrating records that may have been structured using medical coding conventions rather than veterinary-specific record formats.
Veterinary and Dental DSO/MSO M&A: Frequently Asked Questions
Which states prohibit lay ownership of veterinary or dental practices, and how does the MSO structure address that prohibition?
California, New York, Illinois, Texas, and New Jersey are among the states that most strictly prohibit lay ownership of professional practices under corporate practice of medicine, dentistry, or veterinary medicine doctrine. In these states, a non-licensed entity cannot directly own a professional practice entity, cannot employ licensed professionals in a way that gives the lay entity control over clinical decisions, and cannot structure a transaction so that economic rights in the professional practice flow to a lay investor without restriction. The Management Services Organization structure addresses this prohibition by separating the clinical entity, which is owned by a licensed professional and holds the clinical licenses, from the management services entity, which is owned by the investor group and provides administrative, operational, and financial services to the clinical entity under a long-term management services agreement. The management fee paid from the clinical entity to the MSO captures the economic value generated by the practice without transferring ownership of clinical operations. The key compliance requirement is that the management fee must be calibrated to reflect fair market value for the services actually provided by the MSO, because an above-market management fee that extracts substantially all clinical revenue will be treated by regulators as a device for circumventing the lay ownership prohibition.
How enforceable is a management services agreement fee in a state with strict corporate practice of medicine doctrine?
The enforceability of a management services agreement fee in a CPOM state depends on whether the fee has been set at fair market value as determined by an independent valuation, whether the services provided by the MSO in exchange for the fee are genuinely substantive and separable from clinical operations, and whether the professional entity retained by the licensed professional retains meaningful independent clinical authority. Regulators and courts in CPOM states evaluate MSO arrangements by substance rather than form. An MSO fee that extracts ninety-five percent of the professional entity's net revenue, where the MSO controls scheduling, billing, staffing, and equipment, and where the licensed professional exercises no material operational authority, is likely to be treated as a disguised lay ownership arrangement. A well-structured MSO fee covers technology, real estate, administrative staff, marketing, compliance, and operational overhead at rates supported by an independent fair market value opinion. An FMV opinion from a qualified healthcare valuation firm is the primary defense against a regulatory or legal challenge to the fee. In states such as California and New York, that opinion should be updated regularly because regulators will scrutinize changes in practice revenue relative to the management fee over time.
How is a DEA registration transferred when a veterinary or dental practice is acquired?
A DEA registration is issued to a specific registrant at a specific registered location and cannot be transferred to a different legal entity or a different address by operation of an asset or stock acquisition. When a veterinary or dental practice is acquired and the acquiring entity is different from the registered entity, the acquiring entity must apply for a new DEA registration using Form 224 for practitioners or Form 224a for renewal. The new registration application must be submitted before the acquiring entity begins handling, administering, dispensing, or prescribing controlled substances under the new ownership structure. DEA does not recognize a de facto continuation of a predecessor entity's registration in an asset transaction. In a stock transaction where the registered entity continues to exist with new ownership, the existing registration remains valid for that entity, but a change of responsible party or a change of address must be reported to DEA. State controlled substance licenses, which are separate from the DEA registration, must also be assessed on a state-by-state basis because most states issue controlled substance licenses to the entity or to the individual practitioner and have their own transfer, assignment, or reissuance rules that operate independently of the federal DEA process.
Can non-compete agreements be enforced against associate veterinarians or associate dentists after an acquisition?
The enforceability of non-compete agreements against associate practitioners in veterinary and dental practices depends heavily on the state where the associate is licensed and practices. California prohibits non-compete agreements for employees under Business and Professions Code Section 16600, which was reinforced by AB 2288 effective January 1, 2024, eliminating the longstanding narrow exceptions that had allowed some healthcare non-competes in California. New York's 2024 legislation similarly restricted non-compete enforceability for employees earning below a specified threshold, with ongoing litigation about the scope of the restriction. Massachusetts enacted a non-compete reform statute in 2018 that limits non-competes for employees to one year in duration, requires garden leave pay or other consideration, and prohibits non-competes for certain categories of workers. In states such as Michigan, Florida, and Texas that permit reasonable non-compete provisions with appropriate geographic and temporal scope, a well-drafted non-compete for an associate practitioner must be tailored to the legitimate business interest being protected, which in a dental or veterinary practice context typically means the patient or client relationship and the goodwill transferred in the acquisition. Acquiring entities should obtain state-specific analysis of associate non-compete enforceability before relying on those provisions as a mechanism for protecting the acquired patient base.
What professional liability tail coverage is required when a dental or veterinary practice changes hands?
Professional liability insurance in the dental and veterinary sectors is typically written on a claims-made basis, which means the policy only covers claims made during the policy period, not claims arising from incidents that occurred during the policy period but are reported after it ends. When a practice is acquired and the seller's claims-made policy is terminated, the seller requires a tail endorsement, also called an extended reporting period endorsement, to cover claims that are reported after the policy terminates for incidents that occurred during the seller's coverage period. The buyer's obligation to maintain tail coverage for the seller, or the seller's obligation to obtain and pay for its own tail, must be explicitly addressed in the purchase agreement. The cost of tail coverage varies by specialty, claims history, and the length of the tail period selected, but it can represent a material cost that affects transaction economics if not addressed early in negotiation. For veterinary practices that provide emergency or surgical services, and for dental practices performing oral surgery or complex restorative procedures, tail premiums can be significant. The buyer must also arrange its own occurrence-based or new claims-made coverage effective at closing to ensure there is no gap in coverage for incidents arising after the transaction date.
What are the risks of EMR and practice management system migration in a veterinary or dental acquisition?
Electronic medical record and practice management system migration is one of the most operationally complex post-closing integration tasks in veterinary and dental acquisitions, and it is a source of patient safety risk, regulatory exposure, and revenue cycle disruption if not planned carefully. Veterinary practices commonly use AVImark, ezyVet, or Cornerstone as their practice management systems. Dental practices commonly use Dentrix, Eaglesoft, or Open Dental. When a consolidator integrates an acquired practice into its platform system, patient records, appointment histories, treatment plans, medical histories, and billing records must be migrated without data loss, data corruption, or unauthorized access during the migration window. HIPAA requires that patient records be protected during migration and that any data transfer to a new system be conducted under appropriate data use agreements with the technology vendors involved. For veterinary practices, state record retention requirements govern how long patient records must be preserved after a migration, and the acquiring entity must ensure that legacy records remain accessible for the applicable retention period even after migration to the new system. Revenue cycle disruption during migration, including delayed claims submission, incorrect mapping of procedure codes, and billing system downtime, can result in collections shortfalls in the months following closing that affect the acquiring entity's ability to service acquisition debt and that create disputes about earnout calculations if the purchase agreement links earnout payments to revenue metrics during the integration period.
How long does state veterinary board or dental board approval take, and does it create a closing risk?
State veterinary board and dental board approval timelines vary considerably by state and by whether the transaction requires board approval of a change of ownership, assignment of a facility license, or simply notification of a change in the professional entity's structure. Some states, including California and New York, have formal change of ownership approval processes for dental or veterinary facilities that can take sixty to one hundred twenty days from submission of a complete application. Other states require notification without formal approval, which is less of a scheduling risk but still requires accurate and timely filing. The closing risk created by board approval requirements depends on whether the purchase agreement makes board approval a condition precedent to closing or allows closing to occur with board approval as a post-closing obligation. Making board approval a condition precedent reduces the buyer's risk of operating without required authorization but extends the timeline to closing and gives the seller an argument for terminating the agreement if approval is delayed. Experienced counsel will structure the approval process to run concurrently with other diligence and negotiation tasks to compress the overall timeline, and will negotiate a reasonable outside closing date that accounts for board approval lead times in the relevant states.
What dental Medicaid compliance issues arise in a DSO acquisition?
Dental practices that participate in state Medicaid programs, including CHIP-funded children's dental programs, are subject to federal and state Medicaid regulations that govern billing practices, provider enrollment, and the permissible structure of arrangements between the participating provider and any management services organization. The Stark Law, which prohibits physician self-referral under the Medicare program, does not directly apply to dentistry, but the Anti-Kickback Statute applies to Medicaid-funded dental services and prohibits arrangements that involve remuneration intended to induce or reward referrals of Medicaid patients. A DSO that receives a management fee from a dental practice participating in Medicaid must ensure that the management fee arrangement qualifies for protection under an Anti-Kickback Statute safe harbor, most commonly the personal services safe harbor, which requires that the aggregate compensation under the arrangement be set in advance, be consistent with fair market value, and not be determined in a manner that takes into account the volume or value of referrals. Billing irregularities in Medicaid dental programs, including upcoding, unbundling, billing for services not rendered, and billing under an incorrect provider number, create False Claims Act exposure that travels with the practice entity in a stock acquisition. Buyers must conduct targeted Medicaid billing diligence, including a sample audit of submitted claims against treatment records, before assuming responsibility for a dental practice with significant Medicaid revenue.
What does clinical integration timeline look like in a veterinary or dental platform acquisition?
Clinical integration in a veterinary or dental platform acquisition typically unfolds across three phases. The pre-closing phase involves completing diligence, negotiating the purchase agreement, obtaining regulatory approvals, and establishing the MSO structure and management services agreement terms. The immediate post-closing phase, generally spanning the first thirty to ninety days after closing, involves onboarding the acquired practice into the platform's administrative systems, transitioning payroll and benefits, executing associate employment agreements or independent contractor agreements, and establishing the management fee payment schedule. The extended integration phase, spanning months three through twelve, involves practice management system migration, standardization of clinical protocols and supplier contracts, integration of the acquired practice's patient population into the platform's marketing and retention programs, and optimization of the management fee structure based on actual practice performance. Delays in any phase create revenue cycle risk, patient retention risk, and associate retention risk. The most common point of failure in clinical integration is the concurrent loss of key associate practitioners and key administrative staff in the first sixty days after closing, which can be mitigated by retention agreements, earnout structures tied to continued employment, and a deliberate communication strategy that treats the acquired team as a strategic asset rather than a back-office cost center.
How does veterinary scope creep affect M&A diligence in specialty and emergency practice acquisitions?
Veterinary scope creep refers to the practice of general veterinary practitioners providing specialist-level services, such as orthopedic surgery, oncology, internal medicine, or advanced imaging interpretation, without the specialist credentials that would be required if the practice were credentialed as a specialty referral center. In a general practice acquisition, scope creep creates professional liability risk if an adverse outcome arises from a procedure that exceeded the practitioner's training or the practice's standard of care. It creates regulatory risk if the state veterinary board reviews the practice's clinical records and determines that practitioners were performing procedures outside their competency. And it creates valuation risk if a portion of the acquired practice's revenue derives from specialty services that cannot be sustained after the acquisition because the practitioner who performed them has departed or the acquiring entity cannot credential the practice to continue offering those services. Diligence on scope creep requires review of the practice's procedure mix relative to the credentials and training of the practitioners, assessment of whether the revenue associated with complex procedures is tied to specific individuals who may not remain post-closing, and evaluation of whether the practice's malpractice coverage extends to the procedures being performed or whether specialty procedures have been excluded from coverage as outside the practice's standard scope.
Related Resources
DSO and MSO Corporate Practice of Medicine Structure in M&A
Friendly PC model, MSO asset ownership, management fee calibration, and CPOM compliance mechanics for dental and veterinary platform transactions.
DEA and State Veterinary and Dental License Transfer in M&A
Form 224 registration, state controlled substance license transition, and board approval timelines for veterinary and dental practice acquisitions.
Clinical Integration and Associate Employment Agreements in M&A
Associate employment structure, non-compete enforceability by state, retention agreements, and post-closing clinical integration planning for practice platform acquisitions.
About the Author: Alex Lubyansky is the managing partner of Acquisition Stars Law Firm and leads every client engagement personally. Alex advises buyers, sellers, and investors on M&A transactions across veterinary, dental, and professional practice sectors, with particular focus on MSO structure, CPOM compliance, and regulatory diligence in healthcare-adjacent transactions. Acquisition Stars is located at 26203 Novi Road Suite 200, Novi MI 48375. Contact: 248-266-2790 or consult@acquisitionstars.com. This guide is provided for informational purposes and does not constitute legal advice. Readers should consult counsel regarding the specific facts of their transaction.